UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

February 1926, 2026

Date of Report (Date of Earliest Event Reported)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)


Delaware	001-36794	46-4845564
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
Of Incorporation)	File Number)	Identification No.)

1007 Market Street

Wilmington, Delaware 19801

(Address of principal executive offices)

Registrant’s telephone number, including area code: (302) 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol(s)	Name of Exchange on Which Registered
Common Stock ($0.01 par value)	CC	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company		☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.		☐

Item 28.~~02 Results~~01 Other ~~of Operations and Financial Condition~~Events.

On February 1926, 2026, The Chemours Company ~~(the~~issued ~~“Company”)~~press ~~issued~~releases aannouncing ~~press~~the ~~release~~launch ~~regarding~~and pricing of its ~~fourth~~offering ~~quarter~~of ~~and~~$700,000,000 ~~full~~aggregate ~~year~~principal ~~2025~~amount ~~financial~~of ~~results~~7.875% Asenior ~~copy~~unsecured ofnotes ~~the~~due ~~press~~2034 ~~release~~in isa ~~furnished~~private ~~hereto~~offering asthat ~~Exhibit~~is ~~99.1.~~exempt ~~The~~from ~~Company~~the ~~will~~registration ~~post~~requirements toof ~~its~~the ~~investor~~Securities ~~relations~~Act ~~website~~of 1933, ~~investors~~as amended.~~chemours.com,~~ anThe ~~investor~~offering ~~presentation~~size bywas ~~8:00~~increased ~~a.m.~~from ~~Eastern~~the ~~Daylight~~previously ~~Time~~announced onoffering ~~Friday,~~size ~~February~~of 20$600, ~~2026~~000,000 ~~for~~aggregate ~~its~~principal ~~conference~~amount ~~call~~of ~~scheduled for that time~~notes.

~~The~~A ~~information~~copy ~~furnished~~of ~~with~~the ~~this~~foregoing ~~report~~press onreleases ~~Form~~are ~~8-K,~~attached ~~including~~hereto ~~Exhibit~~as Exhibits 99.1, ~~shall~~and ~~not~~99.2 ~~be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,~~ and itare ~~will not be deemed~~ incorporated ~~by reference~~ into ~~any~~this ~~registration~~Item ~~statement~~8.01 ~~or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth~~ by ~~specific~~ reference ~~in such a filing~~.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Launch Press ~~release~~Release, dated as of February 1926, 2026, issued by The Chemours Company.

~~104 The~~Exhibit ~~cover~~99.2 Pricing ~~page~~Press ~~from~~Release, ~~this~~dated ~~Current~~as ~~Report~~of onFebruary ~~Form~~26, ~~8-K~~2026, ~~formatted~~issued inby ~~Inline~~The ~~XBRL~~Chemours Company.

104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CHEMOURS COMPANY
By:		/s/ Shane Hostetter
		Shane Hostetter
		Senior Vice President, Chief Financial Officer
Date:		February 1926, 2026

Filing Compare · Chemours Co